Philadelphia Regional Lab 10.03.2026

Breadcrumb

Home
Philadelphia Regional Lab 10.03.2026

Please register for our Philadelphia Regional Lab

Date: Saturday, October 3rd, 2026
Time: 7:45 AM – 12:30 PM
Location: Penn Pain Medicine (1840 South Street Tuttleman Building, 2nd Floor Philadelphia, PA 19146)

Warning message

No more submissions are permitted.

Leave this field blank

Healthcare Professionals
Patients & Caregivers
- SPRINT® PNS System
- Resources
About Us
News
Events
Careers
- Overview
- Job Listing
Contact Us

Compliance
Consumer Health Data Request Form
CPRA Requests
FCOI Policy
Indications for Use
MRI Safety Information
Patent Information
Product Terms and Conditions
Safety Information
Trademarks
Billing Portal

Consumer Health Data and Information Privacy Policy
Terms of Use

Visit us on Facebook

Visit us on Twitter

Visit us on Instagram

Visit us on YouTube

Visit us on LinkedIn

The SPRINT Peripheral Nerve Stimulation (PNS) System is indicated for pain management in adults who have severe intractable chronic pain of peripheral nerve origin, as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach. It is intended to be implanted for up to 60 days and provide sustained pain relief for up to 3 months after the end of treatment. The SPRINT PNS System is not intended to be placed in the region innervated by the cranial and facial nerves. Refer to Indications for Use for the SPRINT System’s additional indication referencing acute pain.

Physicians should use their best judgment when deciding when to use the SPRINT PNS System. For more information see the SPRINT PNS System IFU. Most common adverse events are skin irritation and erythema. Results may vary. Rx only.

View references for support of all claims.

Product and brand names/logos are registered or common law trademarks of SPR.